Efficacy of Acupuncture Sites for Delivery of Agents to Control Estrus and Ovulation in Mares

This study was designed to determine if prostaglandin F₂α (PGF₂α) when administered on d 6 post-ovulation in a low dose in the lumbosacral space (LSS) would induce luteolysis while minimizing side effects usually associated with intramuscular administration of this analogue in mares. A second objective was to determine if human chorionic gonadotropin (hCG) injected into the LSS would reduce time to ovulation in the mare. Ten normally cycling mares served as their own controls in a crossover design, receiving intramuscular injections of PGF₂α(10 mg), intravenous injections of hCG (3000 IU) and injections of PGF and hCG at the acupuncture site (2 mg and 3000 IU, respectively), as well as sham injections of saline. Beginning 12 h after injection, mean progesterone concentrations were less (P<0.05) in PGF₂α-treated mares than in mares receiving saline. Moreover, progesterone concentrations were similar (P<0.001) between both groups of mares receiving PGF₂α. In addition, there was no difference (P>0.1) between mares receiving the acupuncture injection of PGF₂α and the intramuscular injection in days to ovulation. However, duration and severity of side effects associated with PGF₂α administration were dramatically decreased (P<0.01) when PGF₂α was delivered to the acupuncture site compared to intramuscular delivery. The time to ovulation was similar (P>0.1) for mares receiving shams, or hCG. These data indicate that delivery of 2 mg of PGF₂α in the LSS induces luteolysis and reduces the sweating and muscle cramping associated with PGF₂α administration. There was no advantage to the delivery of hCG in the LSS.     

Efficacy of ivermectin in controlling Strongyloides westeri infections in foals

Twenty-eight foals whose dams were treated IM with ivermectin (200 micrograms/kg of body weight) on the day of parturition were compared with 35 foals whose dams were administered only the vehicle. The effect of ivermectin on the vertical transmission of Strongyloides westeri and foal heat diarrhea was determined by a comparison of results obtained in the 2 groups. Foals from treated mares had significantly fewer S westeri eggs per gram of feces from 17 to 28 days postpartum. There were no differences observed in the frequencies of severity of foal heat diarrhea between the treated and control groups. In another experiment, using the same foals, 32 foals were treated IM with ivermectin (200 micrograms/kg) at 21 days of age and were compared with 31 foals administered only the vehicle. Significantly fewer S westeri eggs were recovered from the ivermectin-treated foals on day 26 to day 32, the completion day of the trial.     

Safety of altrenogest in pregnant mares and on health and development of offspring

Fifty-one light-horse mares were utilized to evaluate the safety of an oral progestin, altrenogest, administered throughout gestation on: gestation length, embryonic and fetal loss, periparturient events, health and development of offspring, and future reproductive capabilities of the mares. Pregnancies were established by inseminating mares with 250 × 10⁶ progressively motile spermatozoa from the same stallion every other day throughout estrus or by non-surgical transfer of embryos. Mares were randomly assigned to 1 of 2 treatments upon confirmation of pregnancy on day 20: 1) controls, 2 ml of neobee oil orally per 44.5 kg of body weight; and 2) treated, 2 ml of altrenogest dissolved in neobee oil at a concentration of 2.2 mg/ml orally per 44.5 kg of body weight. Treatments were administered daily from day 20 to 320 of gestation.There were no significant differences between treatment groups for duration of gestation, placental weight, time to placental expulsion and incidence of retained placental membranes. Number of female foals born from altrenogest treated mares (14 of 23) was greater (P<.05) than the number from untreated control mares (4 of 16). Female foals born from altrenogest treated mares had larger clitori (P<.05) than those from control mares. Times to sternal recumbency, standing and nursing were similar for the 2 groups (P>.05). Body weight and height at withers, heart girth circumference and length and width of cannon were measured at time of birth and at 2, 4, 6, 8, 12 and 16 weeks of age. Measurements did not differ (P>05) between treated and control foals for any development parameters.Beginning on day 20 postpartum, mares were teased daily. During estrus, mares were inseminated every other day with 250 × 10⁶ motile spermatozoa. Teasing and/or insemination was continued for 2 cycles or until mares were 35 days pregnant. The number of mares pregnant after 1 cycle and after 2 cycles of insemination was similar (P>.05) for treated and control mares. Nineteen of 21 treated mares and 15 of 16 control mares were pregnant after 2 cycles of insemination. Number of cycles per pregnancy was similar (P>.05) for treated and control mares (1.37 vs 1.13) as was number of days mares exhibited estrus (6.30 vs 6.13). Number of inseminations per cycle did not differ (P>.05) between treated and control mares (2.92 vs 3.00). In summary, there was no effect of treatment with altrenogest from day 20 to 320 of gestation on periparturient events, viability and growth of offspring and subsequent reproductive performance of mares.     

Effect of altrenogest‐treatment of mares in late gestation on adrenocortical function,blood count and plasma electrolytes in their foals

Reasons for performing study: Mares with compromised pregnancies are often treated with altrenogest to prevent abortion. However, there is only limited information about effects on the foal when altrenogest treatment is continued during final maturation of the fetus. Objectives: To determine effects of altrenogest treatment during late gestation in mares on maturity, haematology changes, adrenocortical function and serum electrolytes in their newborn foals. Methods: Six mares were treated with altrenogest (0.088 mg/kg bwt) once daily from Day 280 of pregnancy until foaling and 7 mares served as controls. Results: Foals born to altrenogest‐treated mares had a significantly lower neutrophil/lymphocyte ratio on the first day after birth than control foals (P<0.05). Basal plasma cortisol concentrations immediately after birth were higher in foals of altrenogest‐treated mares than in control foals (P<0.05). Cortisol release in response to exogenous adrenocorticotropic hormone (ACTH) ‐ except for higher values 15 min after ACTH injection in foals of altrenogest‐treated mares on Day 1 ‐ revealed no differences in adrenocortical function between the groups of foals. Plasma potassium concentration in foals from altrenogest‐treated mares compared to control foals was significantly lower immediately after birth (P<0.05) and plasma ionised calcium concentration was significantly lower 3 h after birth (P = 0.01). Conclusions and potential relevance: Altrenogest treatment of pregnant mares prolonged labour had no major effects on adrenocortical function in foals. A reduced neutrophil/ lymphocyte ratio in these foals may suggest either immunomodulatory effects of altrenogest or dysmaturity of the foals.     

Epidemiologic survey of diarrhea in foals

Epidemiologic and etiologic data about diarrhea in foals were collected under a planned prospective recording and monitoring study. The survey and monitoring procedures included a survey to obtain an overview of current horse management practices on participating farms, a daily health record survey to obtain information on mares and their foals, and collection of feces from 19 of 144 diarrheic foals and 10 age-matched nondiarrheic foals for electron microscopy, ELISA for rotavirus, and bacteriologic culture. Coronavirus was detected in the feces of diarrheic as well as clinically normal foals. Rotavirus was detected in the feces of diarrheic foals only. With regard to agents found in the feces, there was no significant (P less than 0.05) difference between diarrheic and nondiarrheic foals. Half of the 297 foals on which data were available developed diarrhea. Most foals that developed diarrhea lacked other clinical manifestations of disease. Basic cleanliness at foaling was associated with a lower percentage of foals developing diarrhea. Prophylactic use of antibiotics and vitamins in newborn foals was associated with a higher percentage of foals developing diarrhea. A higher percentage of foals born to visiting mares developed diarrhea, compared with foals born to resident mares.     

Comparative effects and safety of ivermectin in pregnant mares

Mares (n=20) approaching 3 months of pregnancy were assigned randomly to 1 of 4 treatment groups. Treatments were (a) an IM injection of ivermectin at 600 mcg/kg, (b) various conventional anthelmintic drugs at the manufacturers' recommended dose, (c) and IM injection of the ivermectin vehicle (placebo) and (d) no anthelmintic treatment during the trial. All anthelmintic treatments were administered at 60-day intervals up to and including the date of parturition. Fecal egg counts, arginase, hemoglobin and packed cell volume values were determined at bi-weekly intervals during the trial and there were no statistically significant differences determined between the treatment groups for these parameters. None of the mares showed any adverse clinical signs during the course of this study and all 20 mares delivered live foals which remained on the research farm until they were sold as year-lings. Mares treated with ivermectin had significantly (P<0.01) lower egg per gram counts than mares in the conventional treatment group. Multiple hematological and clinical chemistry values were determined for all mares and resulting foals within 12 hours post-parturition. A one-way analysis of variance showed no clinically relevant statistically significant differences between treatment groups in either mares or foals at 12 hours post-parturition. This study suggests that ivermectin at 600 mcg/kg is safe and highly efficacious when administered to pregnant mares.     

Effects of inoculum size on cell-mediated and humoral immune responses of foals experimentally infected with Rhodococcus equi: A pilot study

The objective of this pilot study was to compare the cytokine profile as well as cell-mediated and antibody responses of foals infected with a low inoculum of virulent Rhodococcus equi resulting in subclinical pneumonia to that of foals infected with a high inoculum resulting in severe clinical pneumonia. The mean (±SD) ratio of post-infection to pre-infection anti-R. equi IgG(T) concentration was significantly (P = 0.002) higher in foals infected with the high inoculum (195 ± 145; range 62–328) compared to foals infected with the low inoculum (3.9 ± 4.5; range 0.5–11). Similarly, mean (±SD) ratio of post-infection to pre-infection IgM concentration was significantly (P = 0.002) higher in foals infected with the high inoculum (12 ± 4.0; range 7.4–14) compared to foals infected with the low inoculum (2.5 ± 1.5; range 1.2–4.7). Proliferative responses to R. equi antigens as well as expression of mRNA for IL-2, IL-4, IL-10, and IFN-γ in BLN were not significantly different between the two groups. There was a tendency (P = 0.073) towards a higher IFN-γ/IL-4 ratio in the low inoculum group. This study demonstrates that the size of inoculum modulates the IgG subisotype response and possibly the cytokine profile of foals.     

The effect of a spot-on formulation containing polyunsaturated fatty acids and essential oils on dogs with atopic dermatitis

Recent studies have shown that immunological aberrations and epidermal barrier defects could be important in the pathogenesis of canine atopic dermatitis (CAD) and that oral polyunsaturated fatty acids (PUFAs) might influence the epidermal barrier. The aim of this study was to evaluate the effects of a spot-on formulation containing PUFAs and essential oils on pruritus and lesions caused by CAD. Forty-eight privately owned dogs of different breeds, ages and genders diagnosed with atopic dermatitis were included in a randomized, double-blinded, placebo-controlled, multicentre clinical trial. Dogs were treated with a spot-on formulation containing PUFAs and essential oils or placebo on the dorsal neck once weekly for 8 weeks. Before and after the study, CAD extent and severity index-03 (CADESI-03) and pruritus scores were determined by veterinarians and owners, respectively.There was significantly more improvement in CADESI-03 and pruritus scores in the treatment group than in the placebo group (P = 0.011 and P = 0.036, respectively). Additionally, more dogs improved by at least 50% in CADESI-03 and pruritus scores in the treatment group than in the placebo group (P = 0.008 and P = 0.070, respectively). No adverse reactions were observed. The topical preparation containing PUFAs and essential oils was a safe treatment and beneficial in ameliorating the clinical signs of CAD.     

Dystocia in Friesian mares: Prevalence,causes and outcome following caesarean section

Friesian horses appear to suffer a relatively high incidence of dystocia but there are, to the authors' knowledge, no published reports on the incidence or types of dystocia in Friesian horses. A retrospective survey of clinical details and post treatment recovery was performed for 66 mares referred to Wolvega Equine Hospital for dystocia during 2001–2006. Friesian mares appear to be particularly prone to dystocia due to fetal ankylosis or transverse presentation. However, despite dystocia of relatively long duration prior to caesarean section, post operative survival and fertility of mares and, more surprisingly, survival of foals were similar to those reported in surveys for other breeds.     

Transmission of Lawsonia intracellularis to weanling foals using feces from experimentally infected rabbits

The aim of this study was to investigate whether feces from rabbits experimentally infected with Lawsonia intracellularis were infectious to foals. Two rabbits were infected with L. intracellularis, while two rabbits served as controls. Eight foals received daily feces from either the infected or the control rabbits. All rabbits and foals were monitored daily for clinical signs for the entire study period (21 days for rabbits, 42 days for foals). Feces and blood were collected for the PCR detection of L. intracellularis and serologic analysis, respectively. None of the infected rabbits or foals developed clinical signs compatible with proliferative enteropathy. All infected rabbits and foals shed L. intracellularis in their feces and all seroconverted. The results support the role of rabbits as asymptomatic amplifiers of L. intracellularis and their role as sources of infection for susceptible foals.     

Failure of passive transfer in foals: incidence and outcome on four studs in New South Wales

Objective To determine the regional incidence and effectiveness of treatment of failure of passive transfer (FPT) in foals. Design A study of disease incidence. Animals Eighty-eight foals and 57 mares from four studs in the practice area of the Rural Veterinary Centre were tested. Procedure Foals were tested for their serum IgG and total serum protein (TSP) concentration within the first 72 hours of life. Colostrum was collected from mares and specific gravity determined. FPT and partial failure of passive transfer (PFPT) of immunoglobulins was diagnosed when serum IgG concentrations were < 4 g/L and 4 to 8 g/L respectively. Owners of foals diagnosed with FPT were offered treatment with 1 to 2 L plasma (TSP > 70 g/L); 9 (64%) of the affected foals were treated. Results Fourteen foals (16%) had FPT whereas 15 (17%) had PFPT. There were significant differences between the mean TSP concentration in foals with FPT (42.6 ± 4.2 g/L), PFPT (48.1 ± 3.9 g/L) and those acquiring adequate passive immunity (58.9 ± 5.5 g/L) (P < 0.01). Sixteen (29%) mares had pre-suck colostral specific gravity < 1.060 and 12 (71%) foals raised by these mares had FPT or PFPT. The incidence of severe disease (categorised by a sepsis score > 11, positive culture of bacteria from blood or disease requiring hospitalisation) in all foals in the first 2 months of life was 10%. However, none of the nine foals with FPT that received plasma experienced severe disease. In contrast, foals with PFPT had an increased susceptibility to severe disease (P < 0.001) when compared with normal foals. Conclusion Treatment of foals with FPT may reduce the subsequent incidence of severe disease. Pre-suck colostral specific gravity and foal TSP may be used to predict the likelihood of FPT and PFPT. Even though the number of foals studied is small the results highlight the importance of optimal management practices in reducing the incidence of FPT and disease associated with this process.     

The Effects of Dietary Zinc Concentration and Source on Yearling Bull Growth and Fertility

Yearling Angus bulls (n = 325) were allotted by BW into six pens of equal size. One of three dietary treatments consisting of 1) dietary Zn at 40 ppm, all supplied by zinc sulfate (ZnS); 2) dietary Zn at 40 ppm with 33.3% supplied by zinc proteinate and 66.6% supplied by ZnS (ZnPS); or 3) dietary Zn at 60 ppm, all supplied by ZnS (ZnHi) was delivered to two pen replicates. Initial and final liver biopsies were collected and analyzed for Zn concentration. Scrotal circumference and BW measures were collected at the start and conclusion of the trial. Semen from bulls intended for public sale (n = 167) was collected and evaluated for motility and morphological abnormalities. Bulls with percent normal sperm cell counts < 70% or with motility scores less than fair (motility scores = poor, fair, good, and very good) were considered classification deferred (CD). Following 126 d of treatment, bulls on the ZnHi treatment had a greater (P=0.06) increase in liver Zn concentration than bulls on the ZnS treatment, but not bulls on the ZnPS treatment (P=0.18) (‒9.8, 1.2, and 20.6 ppm for ZnS, ZnPS, and Zn Hi, respectively). No differences in scrotal circumference or ADG were detected. Bulls receiving ZnPS had higher (P<0.05) percent normal sperm cells than did bulls receiving ZnS, but not bulls receiving ZnHi (55.5, 68.9, and 62.5% for ZnS, ZnPS, and ZnHi, respectively). The frequency of CD was less (P<0.05) for bulls on ZnPS and ZnHi treatments than for bulls on the ZnS treatment. In all fertility measures observed in this trial, bulls receiving the ZnPS rated greatest, followed by bulls on ZnHi, and lastly by bulls on ZnS.     

Lactation and reproductive performance of mares fed added dietary fat during late gestation and early lactation

Eighteen pregnant mares were randomly allotted to one of two treatment groups. The control group was fed a conventional concentrate and the fat group was fed a concentrate containing 5% feed-grade rendered fat. Both concentrates had the same nutrient:calorie ratio and were fed in amounts required to maintain zero change in percent body fat of the mares. During the study, which began 60 d prior to expected foaling date and ended 60 d postpartum, mares were monitored for feed intake, body weight, rump fat thickness, ration digestibility, plasma glucose and lipid concentrations, milk composition and reproductive efficiency. Birth weight, growth rate, and plasma glucose and lipid concentrations were also measured in foals. Mares fed fat consumed less concentrate (P<.09 during the last 60 d of gestation but consumed similar amounts of concentrate over 60 d of lactation. Protein and ether extract digestion was higher (P<.05 and P<.09, respectively) in the mares fed fat during the postpartum period. Dietary treatment had no influence on plasma glucose or lipid concentrations of the mares or plasma glucose concentrations of their foals, but foals whose dams were fed fat had higher plasma lipid concentrations at birth (P<.01), d 10 and d 30 (P<.05). Percent fat was higher in milk samples from mares fed fat at d 10 (P<.09, 1.23 vs .99%) and d 60 (P<.01, .72 vs .43%) of lactation. Reproductive performance was not significantly different between treatment groups, however there was a trend for a shorter postpartum interval and fewer cycles per pregnancy in the mares fed added fat. Foals from both groups were of similar size and weight at birth and had similar weight gains over 60 d, however, foals nursing mares fed fat tended to gain more weight in the first week of life (1.85 vs 1.56 kg/d) and have more rump fat at d 60 (.53 vs .44 cm) than foals nursing control mares.     

Induction of parturition in mares: effect on passive transfer of immunity to foals

Parturition was induced in 11 mares, using a synthetic prostaglandin. Eight mares, not treated, were used as controls. There was no significant difference between the serum immunoglobulin G (IgG) concentrations of the treated and control mares. The concentration of IgG in the colostrum of treated mares compared favorably with that reported for naturally foaling mares. Four foals from treated mares died or were euthanatized because of weakness during the 1st 24 hours after birth. The mean IgG concentration in the surviving foals from treated mares at 24 to 36 hours of age was 1,561 mg/100 ml, which was significantly (P less than 0.01) lower than the mean concentration of 2,731 mg/100 ml in foals from control mares. The mean serum IgG concentration in foals from control mares was significantly (P less than 0.01) greater than that of their dams, whereas the mean serum IgG concentration of the foals from treated mares was significantly (P less than 0.01) lower than that of their dams.     

Influence of liver copper status of mare and newborn foal on the development of osteochondrotic lesions

REASON FOR PERFORMING STUDY: To elucidate the highly contentious role of copper in the pathogenesis of osteochondrosis. HYPOTHESIS: There would be no relationship between liver copper concentration of mares and foals and incidence of radiographically detectable osteochondrotic lesions in foals and yearlings was tested. METHODS: Liver copper concentration was assessed in biopsies taken within 4 days after birth from both mares and foals and from the same foals at age 5 months. Biopsies were taken in the standing, sedated animal under ultrasonographic guidance. Radiographs were taken of both hocks (lateromedial, dorsoplantar and dorsomedial-plantarolateral oblique views) and stifles (lateromedial and caudolateral-craniomedial oblique views) at ages 5 and 11 months and scored for the presence and severity of osteochondrotic lesions. RESULTS: Copper concentrations in newborn foals were high with a large variation (351 +/- 201 mg/kg DM). They declined until reaching values comparable to those in mature animals at 5 months (20 +/- 8 mg/kg DM; mares: 19 +/- 20 mg/kg DM). Radiographic osteochondrotic lesions decreased in number and severity from 5 to 11 months. This pattern was more predominant in the stifle than in the hock, as has been described previously. CONCLUSIONS: There was no relationship between foal or mare liver copper concentration and osteochondrosis status at either 5 or 11 months. However, osteochondrotic lesions in foals with low-level copper status at birth decreased significantly less in number and severity than those in foals with high-level copper status at birth. POTENTIAL RELEVANCE: It is concluded that copper is not likely to be an important factor in the aetiopathogenesis of osteochondrosis, but this study indicates that there may be a significant effect of high copper status on the natural process of repair of early lesions.     

Comparison of Swine Diets Containing a Food Waste Product Made with Wheat Middlings and Corn or a Corn/Soybean Diet,

Although pigs will readily consume wet food waste (FW), the high moisture content contributes to spoilage and feeding management problems. The use of a dry, processed FW product was compared with a traditional corn and soybean (CS) diet using growing swine in two performance trials and one digestibility trial. The FW diet contained approximately 20% processed FW (DM basis). In Trial 1, 24 gilts (76.4 kg) housed in eight replicated pens (four pens per treatment) were fed in a 6-wk trial. Intake, BW gain, feed efficiency, and carcass characteristics were compared. Feed intake and BW gain averaged 3.4 and 3.6 kg of DM/d and 0.87 and 0.85 kg/d for gilts fed traditional and FW diets, respectively. There were no differences in these or any other measurements (P>0.05). In Trial 2, 12 barrows (84.3 kg) housed in four replicated pens (two pens per treatment) were fed in a 6-wk trial. Intake, BW gain, feed efficiency, and carcass characteristics were compared. Feed intake and BW gain averaged 3.1 and 3.3 kg of DM/d and 0.62 and 0.71 kg/d for barrows fed traditional and FW diets, respectively. Four growing gilts (68.2 kg) were used to compare digestibility in a crossover design. There were no differences (P>0.10) for DM, CP, ADF, or NDF digestibility when feed intake averaged 1.9 kg of DM/d for both FW and CS diets. The use of up to 20% processed FW may be suitable in commercial swine diets.     

Evaluation of Vitamin E and Selenium Supplementation in Late Gestation on Lamb Survival and Pre-Weaning Growth

This study was conducted to evaluate vitamin E injection and Se in a mineral supplement in late gestation on lamb survival and pre-weaning growth performance. Ewes were grouped in pens based on their fetal count and BW. The feed provided to ewes in late gestation included alfalfa hay, corn, and protein supplement according to NRC (1985) recommendations. Ewes in late gestation were assigned to a 2 × 2 factorial arrangement of treatments within fetal count (single, twin, and triplet + quad). Treatments were no vitamin E or 900 IU of vitamin E injected i.m. per week and 10 or 90 ppm of Se in a mineral supplement fed ad libitum. Within each pen of ewes (8 to 10 head), approximately one-half of the ewes received injectable E beginning 4 wk before the first expected lambing; the other one-half received no vitamin E. Vitamin E treatments ended at lambing time; however, ewes remained on their respective mineral sources during lactation. Lambs were provided access to creep (16% CP, 83% TDN, and fortified with 35,000 IU of vitamin E, 0.27 g of Se, and 50 g of chlortetracycline/909 kg of creep feed) initiated at an average 10 d of age to weaning. Weekly injection of 900 IU of vitamin E did not affect birth BW (BBW) of lambs. However, 90 ppm of Se fed ad libitum improved BBW of lambs (5.06 vs 4.88 kg, P<0.10) with all of the improvement occurring in lambs born to 6- to 7-yr-old ewes (P<0.01). Vitamin E increased (P<0.05) the pre-weaning performance of lambs from 1- to 2- and 6- to 7-yr-old ewes but did not improve the performance in lambs from 3- to 5-yr-old ewes. Multiple-birth lambs from ewes treated with vitamin E had increased survival in 1 of 2 experimental yr (P<0.05). Survival of single-birth lambs was not effected by vitamin E or Se treatment. These results demonstrate that supplementation of 90 ppm of Se fed ad libitum to ewes during late gestation and throughout lactation improved BBW of lambs from 6- to 7-yr-old ewes, and weekly injection of 900 IU of vitamin E to ewes during late gestation increased the pre-weaning growth of lambs from 1- to 2- and 6- to 7-yr-old ewes and may increase the survival of multiple-birth lambs.     

Clinical and pathological effects of flunixin meglumine administration to neonatal foals.

The effects of daily intravenous administration of flunixin meglumine at dosages of 0.55, 1.1, 2.2 and 6.6 mg/kg for five days were examined in neonatal foals. Six two day old foals were used to evaluate the effect of each dosage. Foals were examined every day and blood samples collected on days 1, 3 and 6. All foals were euthanized after six days, necropsied and examined for lesions. The major clinical abnormality was diarrhea, but the incidence was not related to the dosage of flunixin meglumine administered. The foals receiving 6.6 mg/kg of flunixin meglumine had significantly more gastrointestinal ulceration and greater cecal pathology and cecal petechiation scores than those foals treated with saline. The foals in the 6.6 mg/kg treatment group had a greater loss of total protein during the study, but the difference was not significant. There were no statistically significant blood cellular or biochemical alterations associated with the administration of flunixin meglumine. There were no significant clinicopathological differences between healthy foals treated with the recommended dosage of flunixin meglumine and those treated with physiological saline.     

Serum vitamin D,calcium, and phosphorus concentrations in ponies,horses and foals from the United States and Thailand

Vitamin D is essential in calcium and phosphorus regulation, bone physiology, cell proliferation and epithelial integrity. Literature on vitamin D in growing horses is sparse, and the effect of age on vitamin D has not been evaluated in equids in the United States or in tropical countries. The goal of this study was to determine if there was an effect of age on serum 25(OH)D₃ concentrations in equids in the US (Ohio/Kentucky) and Thailand (Chiang Rai and Kanchanaburi) during the same time of the year. Blood samples were collected from healthy ponies (n = 21) and Thoroughbred foals (n = 13), yearlings (n = 10), and horses (n = 20) in Thailand and from Thoroughbred foals (n = 10) and horses (n = 17) in the US. Serum concentrations of 25(OH)D₃, calcium and phosphorus were measured.In both countries, serum 25(OH)D₃ concentrations were lower in foals than in yearlings and adult horses. Serum 25(OH)D₃ concentrations were higher in horses than in ponies in Thailand, but were not different between horses from either country. Calcium concentrations were not different between groups or location. In both countries, phosphorus concentrations were higher in foals than in older groups; however, were not different between ponies and horses. This study shows that independent of geography there are age-related differences in 25(OH)D₃ concentrations in horses and further confirms that 25(OH)D₃ concentrations are lower in horses compared to other species. The information will serve as the basis for future clinical studies and to help understand better the pathophysiology of equine disorders associated with calcium and phosphorus dysregulation.     

Case Study: Synchronization of Estrus and Fertility in Gilts Administered P.G. 600® After Treatment with Regu-mate® for 14 or 18 Days

The objective was to determine the effects of duration of progestin exposure prior to gonadotropin treatment on the synchronization of estrus and fertility in gilts. Gilts were fed daily a complete diet containing 15 mg Regu-mate® (Intervet America Inc., Millsboro, DE) for 14 (n = 19) or 18 (n = 18) d. Twenty-four hours after the last feeding of Regu-mate®, all gilts received an i.m. injection of P.G. 600® [400IU pregnant mare serum gonadotropin (PMSG) and 200 IU human chorionic gonadotropin (hCG); Intervet America Inc.]. Gilts were bred artificially 12 and 24 h after first detection of standing estrus. More 18-d (33.3%) than 14-d treated gilts (5.3%) were in estrus on the peak day (d 4.0) after P.G. 600® injection (P=0.02). The percentage of gilts displaying estrus < 7 d after P. G. 600® injection was greater (P=0.06) for the 18-d treatment (88.9%) than for the 14-d treatment (63.2%). Farrowing rate tended to be greater (P=0.17) for gilts exposed to Regu-mate® for 18 d (75%) compared with 14 d (50%). Total pigs born (P=0.43), pigs born live (P=0.63), stillborns (P=0.62), and total litter weight (P=0.52) were similar between groups. The number of mummified fetuses tended to be higher (P=0.11) for gilts in the 18-d treatment group (0.8 ± 0.2) compared with the 14-d treatment group (0.2 ± 0.3). In summary, the precision of estrus synchronization and reproduction was greater in gilts given P.G. 600® after 18 d compared with 14-d Regu-mate® treatment.